Trial Profile
Response to gabapentin enacarbil in two groups of RLS patients: Previously exposed to long-term treatment with dopaminergic agents versus dopaminergic treatment-naive patients.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Mar 2018
Price :
$35
*
At a glance
- Drugs Gabapentin enacarbil (Primary)
- Indications Restless legs syndrome
- Focus Therapeutic Use
- 09 Mar 2018 Status changed from recruiting to completed.
- 21 Jul 2015 New trial record